chr1-150067964-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_007259.5(VPS45):c.93+14T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_007259.5 intron
Scores
Clinical Significance
Conservation
Publications
- congenital neutropenia-myelofibrosis-nephromegaly syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_007259.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VPS45 | NM_007259.5 | MANE Select | c.93+14T>C | intron | N/A | NP_009190.2 | |||
| VPS45 | NM_001279353.2 | c.-16+358T>C | intron | N/A | NP_001266282.1 | Q9NRW7-2 | |||
| VPS45 | NM_001279354.2 | c.-36+14T>C | intron | N/A | NP_001266283.1 | A0A2R8YE10 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VPS45 | ENST00000644510.2 | MANE Select | c.93+14T>C | intron | N/A | ENSP00000495563.1 | Q9NRW7-1 | ||
| VPS45 | ENST00000698584.1 | c.93+14T>C | intron | N/A | ENSP00000513813.1 | A0A8V8TM00 | |||
| VPS45 | ENST00000644526.2 | c.93+14T>C | intron | N/A | ENSP00000494363.1 | A0A2R8YD95 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at